Back to search

Netherlands· NL-7139faa1438b

Dotagraf 0,5 mmol/ml (voor meervoudig gebruik), oplossing voor injectie

A gadotersäure product containing gadolinium (gd 3+) + gadoteerzuur, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC V08CA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDotagraf 0,5 mmol/ml (voor meervoudig…ATCV08CA02REGISTER NO.NL-7139faa1438bPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Gadotersäure is registered in 12 of 19 countries.

Countries holding a registration under ATC V08CA02 (gadotersäure), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Gadotersäure · ATC V08CA02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GADOLINIUM (Gd 3+) + GADOTEERZUUR
Manufacturer
Bayer B.V.
Country
Netherlands (NL)
ATC code
V08CA02
ATC class
Gadotersäure
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    119005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for gadotersäure.

Graded by severity as the source publishes them — 31 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gadotersäure · interactions on record

31 records

  • 31 moderate

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ccc42ab0-9fb8-4a84-b11d-68e9f26fc4cc
GET /v1/drugs/ccc42ab0-9fb8-4a84-b11d-68e9f26fc4cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h119005_smpc.pdf",
  "strength": null,
  "atc_label": "Gadoteric Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg119005",
  "excipients": [
    "MEGLUMINE",
    "TETRAXETAN 2-WATER",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "GADOLINIUM (Gd 3+)",
    "GADOTEERZUUR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h119005.pdf",
  "authorised_at": "2017/01/11",
  "procedure_number": "DE/H/3944/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "119005",
  "additional_monitoring": "N"
}

See everything about gadotersäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.